Eleva Capital SAS »

Miragen Therapeutics shares owned by Eleva Capital SAS

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Eleva Capital SAS from 13F filings

Historical chart of Eleva Capital SAS investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Eleva Capital SAS consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Eleva Capital SAS

Quarter filed Position value Share count Share price at filing
2026-03-31 $139k 7.1k 19.56

More positions owned by Eleva Capital SAS

CRH Ord (CRH)
Amer Sports Com Shs (AS)
NVIDIA Corporation (NVDA)
Netflix (NFLX)
Alphabet Cap Stk Cl A (GOOGL)
Taiwan Semiconductor Mfg Lt Sponsored Ads (TSM)
Arista Networks Com Shs (ANET)
Amazon (AMZN)
Metropcs Communications (TMUS)
Robinhood Mkts Com Cl A (HOOD)
On Hldg Namen Akt A (ONON)
Boston Scientific Corporation (BSX)
Spotify Technology S A SHS (SPOT)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
Cg Oncology (CGON)

View all positions for Eleva Capital SAS

Top funds holding Miragen Therapeutics

FMR
BlackRock
Vanguard Group
Bellevue Group
Vanguard Capital Management
Fairmount Funds Management
VR Adviser
State Street Corporation
Paradigm Biocapital Advisors
Citadel Advisors
Kynam Capital Management
Geode Capital Management
Balyasny Asset Management
Novo A/S
Baker Bros. Advisors

View all funds holding Miragen Therapeutics